Register for email alerts and news feeds:
This journal | BMJ Group
rss
The most recent version of this article was published on 1 May 2007

Arch Dis Child. Published Online First: 15 March 2007. doi:10.1136/adc.2006.109389
Copyright © 2007 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health.

Original articles

Variations in captopril formulations used to treat children with heart failure: a United Kingdom survey

Hussain Mulla 1, Magdi Tofeig 2, Frances Bu'Lock 2, Nilesh Samani 3 and Hitesh Pandya 2*

1 Centre for Pharmacy Practice Research, United Kingdom
2 Congenital and Paediatric Heart Service Glenfield Hospital, Leicester, United Kingdom
3 Department of Cardiovascular Sciences, University of Leicester, United Kingdom

* To whom correspondence should be addressed. E-mail: hp28{at}leicester.ac.uk.

Accepted 29 November 2006


Abstract

Objective: Different liquid formulations of a drug prepared for use in children cannot be assumed to have therapeutic equivalence. The objective of this study was to ascertain the inter-hospital constancy of unlicensed liquid captopril formulations used to treat children with heart failure in the UK.

Design: A questionnaire-based telephone survey.

Setting: 13 tertiary paediatric cardiac centres in the United Kingdom and 13 large hospitals referring patients to these centres.

Participants: Pharmacists responsible for providing the pharmaceutical input to children with congenital heart disease or a pharmacist designated to cover paediatric services. Also technical staff employed by "specials" manufacturers.

Results: 4 hospitals dispensed captopril tablets for crushing and dissolving in water prior to administration; the remaining 22 used 9 different liquid formulations of captopril. Only 3 cardiac centres and their referring hospitals were found to be using the same liquid captopril formulations; 10 centres and their referring hospitals were using completely different captopril formulations.

Conclusions: This survey shows that paediatric cardiac centres and their referring hospitals use a variety of unlicensed liquid captopril formulations inter-changeably. This degree of inconsistency raises issues about optimal captopril dosing and potential toxicity to a level where its use may influence paediatric cardiac -surgical and -interventional outcomes.

Keywords: captopril, children, heart failure, unlicensed


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

A brief digest of the May issue
Arch. Dis. Child. 2007 92: e5. [Extract] [Full Text] [PDF]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Latest from ADC

 

ADC is co-owned by the RCPCH and is the official journal of the European Academy of Paediatrics

BMJ Careers - Latest Paediatrics and Paediatric Surgery Jobs

Paediatrics and Paediatric Surgery Jobs